Drug intelligence / Profile preview

salmonella-targeted bacteriophage

Development stage
Unknown
Lead developer
Intralytix
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral, Topical
01

Overview

Salmonella-targeted bacteriophage therapy is a therapeutic strategy that utilizes bacteriophages, which are viruses that exclusively infect and kill bacteria, to specifically target and eliminate Salmonella species. [3] This approach is being developed as an alternative to traditional antibiotics, particularly in light of rising antibiotic resistance. [2, 3] The bacteriophages are highly specific, meaning they attack only the target Salmonella bacteria without harming the host's cells or beneficial gut microbiota. [2, 3] The mechanism involves the lytic cycle of the phage, where it injects its genetic material into the bacterium, replicates, and ultimately causes the bacterial cell to burst (lyse), releasing new phages to infect other bacteria. [3] This approach is used both in human medicine to treat infections like gastroenteritis and in the food industry and agriculture as a processing aid to reduce Salmonella contamination on products such as poultry, meat, and fresh produce. [4, 9, 19] Several companies are developing and marketing phage cocktails, which are mixtures of different phages, to provide broad coverage against various Salmonella serovars. [7, 19]

Brand names
SalmoFreshPhageguard S
Other names
salmonella phage therapy
02

Targets

EPS (Salmonella enterica biofilm matrix polysaccharides)LPS (Salmonella enterica lipopolysaccharide)BtuB (Vitamin B12 transporter BtuB)OmpC (Outer membrane porin C)

Beyond the preview

Go deeper on salmonella-targeted bacteriophage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on salmonella-targeted bacteriophage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call